Stock search

Ticker or company name

Compare stocks

Market: US

  • BMYBristol Myers Squibb

Add stock

Ticker or company

Summary

BMY
Bristol Myers Squibb
$62,93Down −0,79%
Year: Up +30%
81/100Ratio would consider buying
Open stock page

Traffic light — 10 checks

CheckBMY5 ✓ 3 — 0 ✕
P/E vs its history14,0
P/E vs industry14,0
Forward P/E9,5
Revenue growth, YoY+4,2%
EPS growth, YoY+52,4%
Net margin18,5%
Net debt / EBITDAn/a—
Free cash flow$9,29 bn
Share count over a year+0,7%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBMYTTMIndustry medianTTM
P/E TTM ↓14,041,8
Forward P/E ↓9,512,4
PEG ↓−4,33,3
P/S TTM ↓2,63,4
EV/EBITDA ↓11,424,0
P/FCF ↓14,014,0

Price, %

  • BMYn/a

Returns

Best WorstNo mark — in between

PeriodBMY
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BMY
Share of “buy”41%
Beat the forecast4 of 4
Average “surprise”+16,6%
Insiders over 12 monthssales $2,53 m

Details are on each stock page.